Development of the human cancer microRNA network

Silence

Volumn 1, Issue 1, 2010, Pages

  Bandyopadhyay, Sanghamitra ^a   Mitra, Ramkrishna ^a   Maulik, Ujjwal ^b   Zhang, Michael Q ^c,d  

^a INDIAN STATISTICAL INSTITUTE   (India)

^b JADAVPUR UNIVERSITY   (India)

^c Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^d TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER SURVIVAL; CARCINOGENESIS; CHRONIC LYMPHATIC LEUKEMIA; COLON CANCER; ESOPHAGUS CANCER; GENE CONTROL; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; HUMAN; KAPOSI SARCOMA; LIVER CANCER; LUNG CANCER; ONCOGENE; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RNA ANALYSIS; SPINE CANCER; STOMACH CANCER; THYROID CANCER; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE; UTERUS MYOMA;

EID: 77953358008     PISSN: None     EISSN: 1758907X     Source Type: Journal    
DOI: 10.1186/1758-907X-1-6     Document Type: Article

References (87)

1. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002, 12:735-739. 10.1016/S0960-9822(02)00809-6, 12007417.
2. Lau N, Lim L, Weinstein E, Bartel D. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294:858-862. 10.1126/science.1065062, 11679671.
3. Lee R, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 94:862-864.
4. Lee R, Feinbaum R, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854. 10.1016/0092-8674(93)90529-Y, 8252621.
5. Reinhart B, Slack F, Basson M, Pasquinelli A, Bettinger J, Rougvie A, Horvitz H, Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-906. 10.1038/35002607, 10706289.
6. Pasquinelli A, Ruvkun G. Control of developmental timing by microRNAs and their targets. Annu Rev Cell Dev Biol 2002, 18:495-513. 10.1146/annurev.cellbio.18.012502.105832, 12142272.
7. Harfe B. MicroRNAs in vertebrate development. Curr Opin Genet Dev 2005, 15:410-415. 10.1016/j.gde.2005.06.012, 15979303.
8. Pasquinelli A, Reinhart B, Slack F, Martindale M, Kuroda M, Maller B, Hayward D, Ball E, Degnan B, Muller P, Spring J, Srinivasan A, Fishman M, Finnerty J, Corbo J, Levine M, Leahy P, Davidson E, Ruvkun G. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000, 408:86-89. 10.1038/35040556, 11081512.
9. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858. 10.1126/science.1064921, 11679670.
10. Lund E, Guttinger S, Calado A, Dahlberg J, Kutay U. Nuclear export of microRNA precursors. Science 2003, 303:95-98. 10.1126/science.1090599, 14631048.
11. Yi R, Qin Y, Macara I, Cullen B. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003, 17:3011-3016. 10.1101/gad.1158803, 305252, 14681208.
12. Hutvàgner G, Zamore P. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002, 297:2056-2060. 10.1126/science.1073827, 12154197.
13. Martinez J, Patkaniowska A, Urlaub H, Luhrmann R, Tuschl T. Singlestranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 2002, 110:563-574. 10.1016/S0092-8674(02)00908-X, 12230974.
14. Khvorova A, Reynolds A, Jayasena S. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003, 115:209-216. 10.1016/S0092-8674(03)00801-8, 14567918.
15. Schwarz D, Hutvagner G, Du T, Xu Z, Aronin N. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003, 115:199-208. 10.1016/S0092-8674(03)00759-1, 14567917.
16. Bartel D, Chen C. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004, 5:396-400. 10.1038/nrg1328, 15143321.
17. Selbach M, Schwanhusser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63. 10.1038/nature07228, 18668040.
18. Lu J, Getz G, Miska E, Alvarez-Saavedra E, Lamb L, Peck D, Cordero AS, Ebert B, Mak R, Ferrando A, Downing J, Jacks T, Horvitz H, Golub T. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838. 10.1038/nature03702, 15944708.
19. Calin G, Ferracin M, Cimmino A. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005, 353:1793-1801. 10.1056/NEJMoa050995, 16251535.
20. Esquela-Kerscher A, Slack F. Oncomirs-microRNAs with a role in cancer. Nat Rev cancer 2006, 6:259-269. 10.1038/nrc1840, 16557279.
21. Volinia S, Calin GA, Liu C, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt R, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris C, Croce C. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103:2257-2261. 10.1073/pnas.0510565103, 1413718, 16461460.
22. Iorio MV, Ferracin M, Liu C, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Mnard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. MicroRNA gene expression deregulation in human breast cancer. Cancer Research 2005, 65:7065-7070. 10.1158/0008-5472.CAN-05-1783, 16103053.
23. Calin G, Sevignani C, Dumitru C, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce C. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004, 101:2999-3004. 10.1073/pnas.0307323101, 365734, 14973191.
24. Croce C, Calin G. MiRNAs, cancer, and stem cell division. Cell 2005, 122:6-7. 10.1016/j.cell.2005.06.036, 16009126.
25. Gregory R, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res 2005, 65:3509-3512. 10.1158/0008-5472.CAN-05-0298, 15867338.
26. McManus M. MicroRNAs and cancer. Semin Cancer Biol 2003, 13:253-258. 10.1016/S1044-579X(03)00038-5, 14563119.
27. Michael M, O'Connor S, van Holst Pellekaan N, Young G, James R. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003, 1:882-891.
28. Calin G, Dumitru C, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002, 99:15524-15529. 10.1073/pnas.242606799, 137750, 12434020.
29. Bullrich F, Croce C. Molecular biology of chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2001, 9-32. Dekker, New York: Chronic Lymphoid Leukemia, Chenson BD.
30. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu C, Croce CM, Harris CC. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. CANCER CELL 2006, 9:189-198. 10.1016/j.ccr.2006.01.025, 16530703.
31. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ. RAS is regulated by the let-7 microRNA family. Cell 2005, 120:635-647. 10.1016/j.cell.2005.01.014, 15766527.
32. Zanette D, Rivadavia F, Molfetta G, Barbuzano F, Proto-Siqueira R, Falcao R, Zago M, Silver W. MiRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Brazilian Journal of Medical and Biological Research 2007, 40:1435-1440.
33. Yu J, Wang F, Yang G, Wang F, Ma Y, ZD, et al. Human microRNA clusters: genomic organization and expression profile in leukemia cell lines. Biochem Biophys Res Commun 2006, 349:59-68. 10.1016/j.bbrc.2006.07.207, 16934749.
34. Marcucci G, Radmacher M, Maharry K, Mrzek K, Ruppert A, PP, et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. The new england journal of medicine 2008, 358:1919-1928. 10.1056/NEJMoa074256, 18450603.
35. Steffen B, Merk S, Dugas M, Markus B, Tidow N, MZ, et al. Identification of acute myeloid leukaemia associated microRNA expression patterns. British Journal of Haematology 2008, 140:153-161.
36. Iorio M, Casalini P, Piovan C, Di L, Merlo A, TT, et al. MicroRNA-205 regulates HER3 in human breast cancer. Cancer Res 2009, 69(6):2195-2200. 10.1158/0008-5472.CAN-08-2920, 19276373.
37. Chang H. RNAi-mediated knockdown of target genes: a promising strategy for pancreatic cancer research. Cancer Gene Therapy 2007, 14:677-685. 10.1038/sj.cgt.7701063, 17541422.
38. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu C, Bhatt D, Taccioli C, Croce CM. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007, 297:1901-1908. 10.1001/jama.297.17.1901, 17473300.
39. Nakajima G, Uchida K, Hayashi K, Xi Y, Takasaki K, Ju J. Non-coding microRNA hsa-let-7g as a novel chemoresponse biomarker for S-1 in colon cancer. Journal of Clinical Oncology 2006, 24.
40. Li T, Li D, Sha J, Sun P, Huang Y. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun 2009,
41. Ligon AH, Morton CC. Leiomyomata: Heritability and cytogenetic studies. Human Reproduction Update 2001, 7:8-14. 10.1093/humupd/7.1.8, 11212080.
42. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798. 10.1016/S0092-8674(03)01018-3, 14697198.
43. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. PLoS Biol 2004, 2:e363. 10.1371/journal.pbio.0020363, 521178, 15502875.
44. Wang T, Zhang X, Obijuru L, Laser J, Aris V, Lee P, Mittal K, Soteropoulos P, JunWei J. A Micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes, Chromosomes & Cancer 2007, 46:336-347.
45. Natali PG, Berlingieri MT, Nicotra MR, Fusco A, Santoro E, Bigotti A, Vecchio G. Transformation of thyroid epithelium is associated with loss of c-kit eeceptor1. Cancer Res 1995, 55:1787-1791.
46. Tanaka T, Umeki K, Yamamoto I, Kotani T, Sakamoto F, Noguchi S, Ohtaki S. C-Kit proto-oncogene is more likely to lose expression in differentiated thyroid carcinoma than three thyroid-specific genes: thyroid peroxidase, thyroglobulin, and thyroid stimulating hormone receptor. Endocr J 1995, 42:723-728. 10.1507/endocrj.42.723, 8574299.
47. Scheffler M, Varnholt H, Konze E, Dries V, Drebber U, Schirmacher P, Schulze F, Dienes H, Odenthal M. Identification of microRNA differentially expressed in hepatocellular carcinoma versus non-tumoral liver tissue. Z Gastroenterol 2007, 01.
48. Raisova M, Hossini AM, Eberle J, Riebeling C, Wieder T, Sturm I, Daniel PT, Orfanos CE, Geilen CC. The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol 2001, 117:333-340. 10.1046/j.0022-202x.2001.01409.x, 11511312.
49. Cory S, Adams JM. The Bcl-2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002, 2:647-656. 10.1038/nrc883, 12209154.
50. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000, 6:513-519. 10.1038/74994, 10802706.
51. Beerheide W, Tan YJ, Teng E, Ting AE, Jedpiyawongse A, Srivatanakul P. Downregulation of proapoptotic proteins Bax and Bcl-X(S) in p53 overexpressing hepatocellular carcinomas. Biochem Biophys Res Commun 2000, 273:54-61. 10.1006/bbrc.2000.2891, 10873563.
52. Thomas A, Pepper C, Hoy T, Bentley P. Bcl-2 and bax expression and chlorambucil-induced apoptosis in the T-cells and leukaemic B-cells of untreated B-cell chronic lymphocytic leukaemia patients. Leuk Res 2000, 24:813-821. 10.1016/S0145-2126(00)00051-5, 10996199.
53. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B. Role of Bax in the apoptotic response to anticancer agents. Science 2000, 290:989-992. 10.1126/science.290.5493.989, 11062132.
54. Ionov Y, Yamamoto H, Krajewski S, Reed JC, Perucho M. Mutational inactivation of the proapoptotic gned BAX confers selective advantage during tumor clonal evolution. Proc Natl Acad Sci USA 2000, 97:10872-10877. 10.1073/pnas.190210897, 27116, 10984511.
55. Tsai W, Hsu P, Lai T, Lin G, Chen C, CL, et al. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 2008,
56. Tamura G. Alterations of tumor suppressor and tumor related genes in the development and progression of gastric cancer. World J Gastroenterol 2006, 12:192-198.
57. Chan JA, Krichevsky A, Kosik K. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Research 2005, 65:6029-6033. 10.1158/0008-5472.CAN-05-0137, 16024602.
58. Wabinga HR, Parkin DM, Wabwire-Mangen F, Mugerwa JW. Cancer in kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int J Cancer 1993, 54:26-36. 10.1002/ijc.2910540106, 8478145.
59. Fakhari FD, Dittmer DP. Charting latency transcripts in kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR. J Virol 2002, 76:6213-6223. 10.1128/JVI.76.12.6213-6223.2002, 136228, 12021355.
60. Chang Y, Cesarman E, Pessin M, Lee F, Culpepper J, Knowles DM, Moore P. Identification of herpesvirus-like DNA sequences in AIDS-associated kaposi's sarcoma. Science 1994, 266:1865-1869. 10.1126/science.7997879, 7997879.
61. Said W, Chien K, Takeuchi S, Tasaka T, Asou H, Cho SK, de Vos S, Cesarman E, Knowles DM, Koeffler HP. Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells. Blood 1996, 87:4937-4943.
62. Marshall V, Parks T, Bagni R, Wang CD, Samols MA, Hu J, Wyvil KM, Aleman K, Little RF, Yarchoan R, Renne R, Whitby D. Conservation of virally encoded microRNAs in kaposi sarcoma associated herpesvirus in primary effusion lymphoma cell lines and in patients with kaposi sarcoma or multicentric castleman disease. The Journal of Infectious Diseases 2007, 195:645-659. 10.1086/511434, 17262705.
63. Samols MA, Skalsky RL, Maldonado AM, Riva A, Lopez MC, Baker HV, Renne R. Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathogens 2007, 3:e65. 10.1371/journal.ppat.0030065, 1876501, 17500590.
64. Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS. MicroRNA targets in Drosophila. Genome Biology 2003, 5(1):R1. 10.1186/gb-2003-5-1-r1, 395733, 14709173.
65. Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K, Yatabe Y, Takamizawa J, Miyoshi S, Mitsudomi T, Takahashi T. Reduced expression of dicer associated with poor prognosis in lung cancer patients. Cancer Sci 2005, 96:111-115. 10.1111/j.1349-7006.2005.00015.x, 15723655.
66. Gene ontology consortium. Nucleic Acids Res, GO-EBI, EMBL-EBI Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK 2006, 34:D322-D326.
67. Hartwell LH, Hopfield JJ, Leibler S, Murray AW. From molecular to modular cell biology. Nature 1999, 402(6761 Suppl):C47-C52. 10.1038/35011540, 10591225.
68. Ravasz E, Somera AL, Mongru MA, Oltvai ZN, Barbasi AL. Hierarchical organization of modularity in metabolic networks. Science 2002, 297:1551-1555. 10.1126/science.1073374, 12202830.
69. Goh K, Cusick ME, Valle D, Childs B, Vidal M, Barabasi A. The human disease network. Proc Natl Acad Sci USA 2007, 104:8685-8690. 10.1073/pnas.0701361104, 1885563, 17502601.
70. Selaru F, Olaru A, Kan T, David S, Cheng Y, YM, et al. MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology 2009,
71. Agrawal R, Imielinski T, Swami A. Mining association rules between sets of items in large databases. Proceedings of the 1993 ACM SIGMOD International Conference on Management of Data 1993, 207-216.
72. Baskerville S, Bartel DP. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 2005, 11:241-247. 10.1261/rna.7240905, 1370713, 15701730.
73. Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao W, Cui Q. An analysis of human microRNA and disease associations. pLoS ONE 2008, 3:e3420. 10.1371/journal.pone.0003420, 2559869, 18923704.
74. Agarwal R, Srikant R. Fast algorithms for mining association rules. Proc VLDB conf 1994, 478-499.
75. Veerla S, Lindgren D, Kvist A, Frigyesi A, Staaf J, Persson H, Liedberg F, Chebil G, Gudjonsson S, Borg, Mnsson W, Rovira C, Hglund M. MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. International Journal of Cancer 2009, 124:2236-2242.
76. Gramantieri L, Fornari F, Callegari E, Sabbioni S, Lanza G, Croce C, Bolondi L, Negrini M. MicroRNA involvement in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 2008, 12:2189-2204. 10.1111/j.1582-4934.2008.00533.x, 19120703.
77. Yu T, Wang X, Gong R, Li A, Yang S, Cao Y, Wen Y, Wang C, Yi X. The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. J Exp Clin Cancer Res 2009, 28. 2651854, 19243631.
78. Lee C, Rennie P, Jia W. MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells. Clin Cancer Res 2009, 15:5126-5135. 10.1158/1078-0432.CCR-09-0051, 19671871.
79. Dalmay T, Edwards D. MicroRNAs and the hallmarks of cancer. Oncogene 2006, 25:6170-6175. 10.1038/sj.onc.1209911, 17028596.
80. Schaefer A, Jung M, Mollenkopf H, Wagner I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G, Jung K. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. International Journal of Cancer 2009, 126:1166-1176.
81. Gaur A, Jewell D, Liang Y, Ridzon D, Moore J, Chen C, Ambros V, Israel M. Characterization of MicroRNA Expression Levels and Their Biological Correlates in Human Cancer Cell Lines. Cancer Research 2007, 67:2456-2468. 10.1158/0008-5472.CAN-06-2698, 17363563.
82. Li Z, Lu J, Sun M, Mi S, Zhang H, Luo R, Chen P, Wange Y, Yanf M, Qiana Z, Neilly M, Jin J, Zhang Y, Bohlander S, Zhang D, Larson R, Beau M, Thirman M, Golub T, Rowley J, Chena J. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci USA 2008, 105:15535-15540. 10.1073/pnas.0808266105, 2563085, 18832181.
83. Varambally S, Cao Q, Mani R, Shankar S, Wang X, Ateeq B, Laxman B, Cao X, Jing X, Ramnarayanan K, Brenner J, Yu J, Kim J, Han B, Tan P, Sinha C, Lonigro R, Palanisamy N, Maher C, Chinnaiyan A. Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer. Science 2008, 322:1695-1699. 10.1126/science.1165395, 2684823, 19008416.
84. Zhang Z, Sun H, Dai H, Walsh R, Imakura M, Schelter J, Burchard J, Dai X, Chang A, Diaz R, Marszalek J, Bartz S, Carleton M, Cleary M, Linsley P, Grandori C. MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 2009, 8:2756-2768.
85. Akao Y, Nakagawa Y, Naoe T. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 2006, 29:903-906. 10.1248/bpb.29.903, 16651716.
86. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T. MicroRNA Expression Profiling in Prostate Cancer. Cancer Res 2007, 67:6130-6135. 10.1158/0008-5472.CAN-07-0533, 17616669.
87. Schultz J, Lorenz P, Gross G, Ibrahim S, Kunz M. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Research 2008, 18:549-557. 10.1038/cr.2008.45, 18379589.